Published in Alzheimer Dis Assoc Disord on December 01, 1998
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Current concepts in mild cognitive impairment. Arch Neurol (2001) 18.09
The Biomolecular Interaction Network Database and related tools 2005 update. Nucleic Acids Res (2005) 12.94
Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials (2000) 10.99
Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet (1985) 8.35
Influence of social network on occurrence of dementia: a community-based longitudinal study. Lancet (2000) 7.31
An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 5.94
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet (2001) 5.72
Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. Neurology (2005) 5.51
Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. BMJ (1999) 5.36
Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest (1999) 5.30
A conformational switch in syntaxin during exocytosis: role of munc18. EMBO J (1999) 5.07
Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol (1992) 4.63
Use of complementary therapies by individuals with 'arthritis'. Clin Rheumatol (1997) 4.49
The rate of blood flow and gaseous metabolism of the uterus during pregnancy. J Physiol (1933) 4.49
Apolipoprotein E polymorphism and Alzheimer's disease. Lancet (1993) 4.47
Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology (1990) 4.41
Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet (1997) 4.39
A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet (1992) 4.31
Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 4.31
Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation (2000) 4.12
Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA (2000) 3.99
Use of subgenic 18S ribosomal DNA PCR and sequencing for genus and genotype identification of acanthamoebae from humans with keratitis and from sewage sludge. J Clin Microbiol (2001) 3.98
The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J Exp Med (1995) 3.86
Surprise! A fungus factory for taxol? Science (1993) 3.84
Caregivers of the frail elderly: a national profile. Gerontologist (1987) 3.67
Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol (1999) 3.62
Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience. Neurology (1997) 3.53
Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet (1997) 3.51
The links between joint damage and disability in rheumatoid arthritis. Rheumatology (Oxford) (2000) 3.48
Occupational therapy for independent-living older adults. A randomized controlled trial. JAMA (1997) 3.47
Lack of health insurance and decline in overall health in late middle age. N Engl J Med (2001) 3.45
Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. N Engl J Med (1999) 3.43
Herpes simplex virus proteins: DNA-binding proteins in infected cells and in the virus structure. Virology (1975) 3.41
Analysis of regulation of Klebsiella pneumoniae nitrogen fixation (nif) gene cluster with gene fusions. Nature (1980) 3.38
Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology (1995) 3.37
Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller's Thrombosis (NZATT) study. Lancet (2003) 3.34
Seizure control and mortality in epilepsy. Ann Neurol (1999) 3.28
Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem (1995) 3.27
A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology (2001) 3.25
Firing modes of midbrain dopamine cells in the freely moving rat. Neuroscience (2002) 3.22
Mutants of herpes simplex virus types 1 and 2 that are resistant to phosphonoacetic acid induce altered DNA polymerase activities in infected cells. J Gen Virol (1976) 3.21
An analysis of a performance feedback system: the effects of timing and feedback, public posting, and praise upon academic performance and peer interaction. J Appl Behav Anal (1975) 3.20
Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice. Arch Neurol (2001) 3.19
Predicting time to nursing home care and death in individuals with Alzheimer disease. JAMA (1997) 3.17
The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. CMAJ (1999) 3.14
Health care contingent valuation studies: a review and classification of the literature. Health Econ (1998) 3.13
Inhibition by acetylene of conventional hydrogenase in nitrogen-fixing bacteria. Nature (1976) 3.11
Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success? Int J Geriatr Psychiatry (2001) 3.09
Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations. Intern Med J (2005) 3.08
MIST VR: a virtual reality trainer for laparoscopic surgery assesses performance. Ann R Coll Surg Engl (1997) 3.04
Effectiveness, efficiency, and NICE. BMJ (2001) 3.03
Treatment of Alzheimer's disease. N Engl J Med (1999) 3.03
Comparing treatments. BMJ (1995) 3.02
Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry (1996) 2.99
Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer (1996) 2.96
Environmental estrogens stir debate. Science (1994) 2.84
The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles. J Virol (1992) 2.80
Safety and efficacy of galantamine in subjects with mild cognitive impairment. Neurology (2008) 2.79
A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology (2001) 2.78
Asymbiotic nitrogen-fixing bacteria from the surfaces of nodules and roots of legumes. Can J Microbiol (1972) 2.76
A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study. Neurology (2000) 2.76
Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology (2007) 2.72
Guam: deadly disease dying out. Science (1993) 2.72
Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine. Cancer Res (1987) 2.72
Altered properties of deoxyribonucleic acid nucleotidyltransferase after infection of mammalian cells with herpes simplex virus. Nature (1966) 2.61
Heritability for Alzheimer's disease: the study of dementia in Swedish twins. J Gerontol A Biol Sci Med Sci (1997) 2.59
Glucose intolerance during diuretic therapy. Results of trial by the European Working Party on Hypertension in the Elderly. Lancet (1978) 2.56
Choosing the correct unit of analysis in Medical Care experiments. Med Care (1984) 2.54
Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. Am J Occup Ther (1999) 2.53
The effects of information framing on the practices of physicians. J Gen Intern Med (1999) 2.52
Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60. Lancet (1986) 2.50
How was your hospital stay? Patients' reports about their care in Canadian hospitals. CMAJ (1994) 2.48
Genetic and biochemical studies with herpesvirus. Cold Spring Harb Symp Quant Biol (1975) 2.47
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol (2007) 2.47
Structure of varicella-zoster virus DNA. J Virol (1981) 2.43
Nitrogen fixation gene (nifL) involved in oxygen regulation of nitrogenase synthesis in K. pneumoniae. Nature (1981) 2.42
Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities. J Neurol Neurosurg Psychiatry (1994) 2.40
The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. Arch Neurol (2000) 2.37
Chlorhexidine or polyhexamethylene biguanide for acanthamoeba keratitis. Lancet (1995) 2.36
Coding strategy of the S genome segment of Hantaan virus. Virology (1986) 2.36
The appropriateness of drug use in an older nondemented and demented population. J Am Geriatr Soc (2001) 2.30
The effects of donepezil in Alzheimer's disease - results from a multinational trial. Dement Geriatr Cogn Disord (1999) 2.30
HLA B*44: protective effects in MS susceptibility and MRI outcome measures. Neurology (2010) 2.29
Validation of 24-hour recalls assisted by food records in third-grade children. The CATCH Collaborative Group. J Am Diet Assoc (1993) 2.29
Gastric intramural pH as a predictor of success or failure in weaning patients from mechanical ventilation. Ann Intern Med (1993) 2.29
Cognitive test performance among nondemented elderly African Americans and whites. Neurology (1998) 2.28
Education and dementia: what lies behind the association? Neurology (2007) 2.26
HSV-1 in brain and risk of Alzheimer's disease. Lancet (1998) 2.21
An approach to evolutionary relationships of mammalian DNA viruses through analysis of the pattern of nearest neighbor base sequences. Cold Spring Harb Symp Quant Biol (1966) 2.20
Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ (1996) 2.20
Assessing patient dependence in Alzheimer's disease. J Gerontol (1994) 2.16